Neuwave
Device Ablation System
PDI 00853719006326
General payments
$549,711
Research payments
$7,031,364
Through program year 2025, $549,711 in general payments and $7,031,364 in research payments were reported against Neuwave (Ablation System).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $346,096 | 236 |
| 2025 | Research | $1,341,597 | 171 |
| 2024 | General | $81,866 | 362 |
| 2024 | Research | $859,638 | 187 |
| 2023 | General | $44,247 | 331 |
| 2023 | Research | $1,854,342 | 196 |
| 2022 | General | $44,472 | 248 |
| 2022 | Research | $2,065,421 | 147 |
| 2021 | General | $33,030 | 297 |
| 2021 | Research | $910,365 | 125 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,474 general · 826 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.